Announced Wed, 30 Sept, 2026 · 20:47 IST

Concord Drugs 31st AGM held on Sep 30, 2026 via video conferencing

Board & Shareholder Meetings View source PDFExplain this filing

Price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close
+2.2%Reaction day
₹74.05
prior close
—
announcement price
After-mkt
timing
Nifty Microcap 250market · in no size index; the smallest one is used-1.3%+3.5% vs market
Pharmaceuticals peers, median of 173sector-0.8%+3.0% vs sector

On the reaction day the stock moved 3.5 pts more than Nifty Microcap 250 and 3.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark
Stock
5m
—
10m
—
15m
—
30m
—
Sessions after the filingfrom the prior close
StockMarketvs marketSectorvs sector
Reaction day
+2.2-1.3+3.5-0.8+3.0
Next day
+4.0-1.3+5.3-1.3+5.2
2d
-1.4+0.0-1.4-0.4-1.0
3d
-2.1-0.2-1.9-0.1-2.0
4d
-4.1-3.0-1.1-3.0-1.1
5d
-3.7-2.7-1.0-3.1-0.6
1w
-3.0-1.7-1.3-3.1+0.1
15d
-10.9-8.9-2.0-6.9-3.9
1m
—————
2m
—————
3m
—————
UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 173Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

Concord Drugs held its 31st AGM on Sep 30, 2026 via video conferencing from 9:30 to 9:50 AM. 63 members attended. 7 resolutions were tabled covering: adoption of FY26 financials, reappointment of statutory auditors for 5 years, approval of related party transactions for FY27, ratification of cost auditor pay, and reappointment of 2 independent directors. Results to be announced after the scrutinizer submits report to BSE.

Likely market impact

Routine AGM covering auditor and director reappointments plus related party transaction approval. Voting results are pending; watch for BSE filing.